This anatomical diagram provides a schematic representation of the horizontal classification of the mental foramen (MF) position relative to the mandibular teeth, commonly used in maxillofacial radiology and surgical planning. The illustration depicts the left mandibular segment from the canine to the first molar. Six specific horizontal positions (H1–H6) are categorized based on their anterior-posterior relationship to the tooth axes: H1 is located between the canine (C) and first premolar (PM1); H2 aligns with the long axis of the PM1; H3 is positioned between the first and second premolars (PM2); H4 aligns with the long axis of the PM2; H5 is located between the PM2 and the first molar (M1); and H6 aligns with the mesial root of the M1. Blue vertical lines illustrate the long axes of the teeth to define these anatomical landmarks. This diagram serves as an educational tool for dental students and clinicians to understand the common anatomical variations of the mental nerve exit point, which is critical for local anesthesia and avoiding neurovascular injury during dental implantation or mandibular surgery.

A pathophysiology diagram and pharmacological algorithm illustrating the mechanisms of chemotherapy-induced nausea and vomiting (CINV) and the corresponding sites of action for anti-emetic agents. The central anatomical figure is a sagittal section of the human brain, highlighting the Higher Centers (processing sensory/emotional stimuli), the Vomiting Center (VC) in the medulla, and the Chemoreceptor Trigger Zone (CTZ). Neural pathways connect these central regions to peripheral effectors including the GI tract and the diaphragm. The diagram maps specific drug classes to their molecular targets: 5-HT3 Receptor Antagonists (5-HT3 RA), NK1 Receptor Antagonists (NK1RA), Dexamethasone, and Olanzapine. These agents are shown inhibiting various receptors including 5-HT3, D2 (dopamine), NK1 (neurokinin-1), and H1 (histamine) receptors within the CTZ and peripheral pathways. Dexamethasone is specifically noted for its role in inhibiting prostanoid influx. Solid red lines represent predominant mechanisms of action, while dashed lines indicate minor pathways. This educational visual summarizes multi-receptor antagonism strategies used in clinical oncology to manage nausea and vomiting reflexes.

This comparison clinical photograph depicts the efficacy of topical antihistamine formulations on induced skin reactions in a rabbit model. The visual is organized into two rows representing time points: 'At Zero Mint' and 'After 15 Mints', subdivided into three experimental groups (A, B, and C). Group A evaluates a novel Ebastine emulgel, Group B serves as a positive control using a standard antihistamine (Benadryl), and Group C acts as the untreated negative control. At 0 minutes, all groups show histamine-induced erythema and wheal formation, with Group C exhibiting the most severe, raised, and inflamed lesion. Surface markings in blue and pink demarcate treatment zones. At 15 minutes, Group A and Group B demonstrate a visible reduction in the intensity and area of erythema, indicating effective drug absorption and inhibition of the H1-receptor-mediated allergic response. In contrast, Group C maintains significant, persistent inflammation and redness. The images illustrate the clinical progression of allergic skin lesions and the therapeutic effect of topical emulgel formulations on inflammatory symptoms like redness and swelling.

This medical flow diagram illustrates the pharmacological discovery and synergy between Lactoferrin and Diphenhydramine against SARS-CoV-2. The pathway starts with two screening methods: high-throughput screening for SARS-CoV-2 antivirals and electronic health record analysis for medications correlated with improved COVID outcomes. These lead respectively to Lactoferrin and Diphenhydramine. Lactoferrin is depicted as a complex structural protein model and described as an iron-binding milk protein with immunomodulating and direct antiviral activity. Diphenhydramine is shown as a chemical ball-and-stick model and identified as a common antihistamine and off-target sigma receptor ligand that prevents the formation of the coronavirus replication complex. Both agents point toward a final node represented by a SARS-CoV-2 virion with a lightning bolt symbol, signifying a 'Synergistic antiviral effect against SARS-CoV-2.' The diagram serves as an educational summary of how multi-modal screening can identify repurposed drug combinations that target different stages of the viral life cycle to enhance therapeutic efficacy.